Abnormal labor
Conditions
Interventions
Treatment group:Phloroglucinol 80mg (dosage form 40mg/4ml/each bottle) dissolved in 8ml of normal saline, intravenous injection.
Control group:Normal saline 8 ml intravenously.
Sponsors
The Fourth Hospital of Shijiazhuang
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: 1. 20-35 years old primiparous mother; 2. Gestational age is 37+0 weeks to 41+6 weeks; 3. Single fetus, cephalic position; 4. Uterine opening dilation 3-5cm; 5. Intended vaginal delivery; 6. No contraindications to vaginal delivery; 7. Intended use of epidural labor analgesia; 8. The estimated weight of the fetus is 2500g-4000g; 9. Class I fetal heart rate waveform.
Exclusion criteria
Exclusion criteria: 1. Does not meet the inclusion criteria; 2. Suspected placental abruption, for example, vaginal bleeding; 3. Chorioamnionitis; 4. Meconium staining of amniotic fluid above II°; 5. Excessive contractions; 6. Fetal growth restriction; 7. Fetal abnormalities; 8. Have a history of labor induction for more than 20 weeks in the past; 9. History of cervical cerclage, cervical conization, cervical treatment, etc.; 10. Patients with severe allergies and immune system diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time from Phloroglucinol Injection to Fetal Delivery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Maternal Outcome Measures; | — |
Countries
China
Contacts
Public ContactHui Du
The Fourth Hospital of Shijiazhuang
Outcome results
None listed